Business
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative...
In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take...
In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss...
In today’s episode of the Psychedelic Spotlight Podcast, James Hallifax from the Psychedelic Investor YouTube Channel interviews Ian McDonald, CEO...
This week in psychedelic business news: more evidence supporting ketamine for depression; a new use for MDMA; Lobe Sciences makes...
The psychedelic bioscience company's top advisor tells Psychedelic Spotlight that psilocybin "affects at least the 5h2C receptor, which is dedicated...
“Women’s desire issues have not been adequately addressed to date, and we believe this treatment incorporating MDMA and psychotherapy has...
MindMed Releases Data on TWO Clinical Trials: A Closer Look Into MMED's Psilocybin and LSD studies. Mind Medicine (MindMed), (NASDAQ:...
In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused...